V. S. Krasnov

V. S. Krasnov

Auto-generated profile, based on publicly available information

V. S. Krasnov

Almazov National Medical Research Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DZD. D. Zubarev
D. D. Zubarev
SSS. V. Sim
S. V. Sim
VKV. S. Krasnov
V. S. Krasnov
AGA. V. Gorbatykh
A. V. Gorbatykh
MCM. A. Chernyavsky
M. A. Chernyavsky
APA. A. Prokhorikhin
A. A. Prokhorikhin
Aortic stenosis is one of the most common valvular heart defects that occurs in patients with oncology after radiation therapy and requires surgical treatment. However, this group of patients has a higher risk of intra- and postoperative complications, and therefore the most optimal method of surgical treatment of aortic stenosis in such a cohort of patients is transcatheter aortic valve implan­tation (TAVI).Brief description. Forty-six-year old woman entered the Almazov National Medi­cal Research Center with a clinical picture of severe aortic stenosis. At a young age, the patient was diagnosed with lymphogranulomatosis, or Hodgkin’s disease, for which radiation therapy was performed, which was complicated in the long term by valvular pathology. After a thorough examination, a high intraoperative risk for the patient was determined by the cardiac team and endovascular treatment of severe aortic stenosis was performed. The postoperative period was complicated by the development of complete atrioventricular block, which caused the implantation of a permanent dual-chamber pacemaker.Discussion. The presented case is an example of successful surgical treatment of aortic stenosis associated with previous radiation therapy for Hodgkin’s disease in a patient.Conclusion. Endovascular aortic valve implantation is a promising approach to the treatment of patients with post-radiation aortic stenosis, since it is associated with unfavorable anatomical and clinical risk factors for surgical valve replacement. Despite their younger age, these patients represent a category of higher surgical risk. Therefore, additional attention should be paid to the planning of the procedure and the prevention of the main TAVI risks.

4 June 2026 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MSM. A. Simakova
M. A. Simakova
SPS. I. Parkhomenko
S. I. Parkhomenko
KLK. B. Lapshin
K. B. Lapshin
TGT. D. Glebovskaya
T. D. Glebovskaya
VKV. S. Krasnov
V. S. Krasnov
OMOlga Moiseeva
Olga Moiseeva
Aim. To compare the efficacy and safety of ultrasound-assisted catheter-directed thrombolysis (UACDT) using EkoSonic technology (EKOS Corporation, Bothell, Washington, USA) and a routine conservative approach with anticoagulant therapy (ACT) in patients with pulmonary embolism (PE) at intermediate-high risk for 30-day mortality. Material and methods. This single-center retrospective study included patients with confirmed intermediate-high-risk PE with thrombosis of the main or lobar branches of the pulmonary artery, no more than 14 days old. The patients were admitted to the cardiology intensive care units of the Almazov National Medical Research Center between January and December 2025. In accordance with the applied treatment strategy, patients were divided into 2 following groups: the UACDT group using EkoSonic technology (EKOS Corporation, Bothell, Washington, USA) and the ACT group. After 48 hours, the effectiveness of the treatment was assessed as follows: the incidence of decompensated hemodynamics episodes, the changes of right ventricle to left ventricle basal diameter ratio (RV/LV), decrease in the Qanadli score and the increase in residual peripheral flow according to computed tomography pulmonary angiography (CTPA), as well as the changes of right ventricular function echocardiographic parameters. Safety criteria included the incidence of minor and major bleeding. A telephone survey of patients was conducted one month after discharge to assess long-term outcomes. Results. The study included 41 patients, which were divided into 2 groups: ACT group — 21 patients; UACDT group — 20 patients. The endovascular treatment group showed a more pronounced reduction in right heart overload: Δ RV/LV according to CTPA was 0,40 [0,20; 0,70] in the UACDT group vs 0,03 [0,00; 0,40] in the ACT group (p=0,012). A reduction in the RV/LV ratio of more than 20% from baseline was achieved in 74% of cases in the UACDT group vs 30% of cases in the ACT group (p=0,010). According to echocardiography, there was a decrease in the right ventricular diameter by 11,0 [6,7; 13,8] mm in the UACDT group vs 6,0 [1,5; 8,5] mm in the ACT group (p=0,015), a decrease in the right atrial area by 5,20 [0,67; 6,25] cm 2 in the UACDT group vs 0,0 [-1,0; 2,8] cm 2 in the ACT group (p=0,050), a reduction in the inferior vena cava diameter by 2,0 [1,0; 6,0] mm in the UACDT group vs 0,0 [-0,5; 2,0] in the ACT group (p=0,040). In 2 cases (10%) in the UACDT group and in 6 cases (29%) in the conservative ACT group, hemodynamic destabilization was recorded (p=0,238), which served as the basis for "rescue" systemic thrombolytic therapy. Hemorrhagic events occurred in 5 cases (25,0%) in the UACDT group and in 2 cases (9,5%) in the ACT group (p=0,538). The incidence of minor and major bleeding was comparable between the groups as follows: 4 minor bleeding events in the UACDT group vs 2 in the ACT group (p=0,992) and 1 major bleeding event in the UACDT group vs 0 in the ACT group (p>0,999). Fatal outcomes were recorded in 1 case (5%) in the UACDT group and in 3 cases (14%) in the ACT group (p=0,606). Conclusion . There is a higher efficacy of UACDT in the form of a reduction in right ventricular overload in patients with intermediate-high-risk PE when compared with standard ACT with a comparable safety profile.

17 November 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AMA. V. Mikhailov
A. V. Mikhailov
DZD. D. Zubarev
D. D. Zubarev
VKV. S. Krasnov
V. S. Krasnov
MCM. A. Chernyavsky
M. A. Chernyavsky
APA. A. Prokhorikhin
A. A. Prokhorikhin
We described a case report of transcatheter aortic valve replacement in conditions when the aortic stenosis anatomy does not make it possible to perform retrograde left ventricular catheterization, and the patient’s condition severity does not allow performing transapical or surgical aortic valve replacement. The presented technique of interatrial septal puncture with antegrade passage of the guidewire through the mitral and aortic valves and the venoarterial looping demonstrates an elegant way to solve this clinical situation, and can be adopted by specialists performing transcatheter interventions in severe aortic stenosis.

12 February 2024 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
NSN.V. Susanin
N.V. Susanin
DZD.D. Zubarev
D.D. Zubarev
VKV.S. Krasnov
V.S. Krasnov
MCM.A. Chernyavsky
M.A. Chernyavsky
The authors present endovascular treatment of abdominal aortic aneurysm in a patient with iliac artery occlusion. After examination and assessment of all perioperative risks, specialists preferred simultaneous endovascular repair of abdominal aortic aneurysm and revascularization of the lower limb. Perioperative period was uneventful. The patient was discharged after 4 postoperative days. The authors justify the choice in favor of minimally invasive treatment. Effectiveness and safety of this approach are also concluded.

28 December 2021 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
AGA.D. Gorovaya
A.D. Gorovaya
ДЗД. Д. Зубарев
Д. Д. Зубарев
ВКВ. С. Краснов
В. С. Краснов
MCM.A. Chernyavskiy
M.A. Chernyavskiy
APA.A. Prokhorikhin
A.A. Prokhorikhin
We report the successful endovascular correction of the migration of a transcatheter aortic valve prosthesis in the left ventricle outflow tract (LVOT). A 72-old man was underwent transcatheter aortic valve implantation (TAVI) at Almazov National Medical Research Centre for severe aortic stenosis. During the procedure, the self-expanding prosthesis dislocated 10–12 mm into the LVOT. The frame was optimised with the use of a balloon catheter, and aortic regurgitation I-II degree was achieved. However, on day 17 of hospitalisation, acute heart failure with episodes of asystole occurred as a result of severe paravalvular regurgitation; cardiopulmonary resuscitation was necessary. The prosthesis malpositioning was corrected by traction with endovascular snare devices. The patient was stable during the postprocedural period and discharged on day 31. Dislocation of self-expanding prostheses into the LVOT is a complication specific to TAVI that may quickly aggravate a patient’s condition; therefore, correction of valve malpositioning should be performed as soon as possible. The case reported here in an illustration of successful endovascular correction of dislocation performed with the snare traction technique. This bail-out approach can be used by interventional cardiologists in similar situations. Received 27 May 2021. Revised 29 July 2021. Accepted 30 July 2021. Funding: The study did not have sponsorship. Conflict of interest: Authors declare no conflict of interest. Contribution of the authorsLiterature review: A.D. Gorovaya, D.D. Zubarev, A.A. ProkhorikhinDrafting the article: A.D. Gorovaya, V.S. Krasnov, A.A. ProkhorikhinCritical revision of the article: A.D. Gorovaya, M.A. Chernyavskiy, A.A. ProkhorikhinSurgical treatment: D.D. Zubarev, V.S. Krasnov, A.A. ProkhorikhinFinal approval of the version to be published: A.D. Gorovaya, D.D. Zubarev, V.S. Krasnov, M.A. Chernyavskiy, A.A. Prokhorikhin